LASER THERAPY IN GASTRIC STOMA INJURIES OF CHILDREN AND ADOLESCENTS
EFFECT OF LASER THERAPY ON MUCOSAL LESIONS OF GASTRIC STOMA OF CHILDREN AND ADOLESCENTS: RANDOMIZED CLINICAL TRIAL
1 other identifier
interventional
70
1 country
1
Brief Summary
Compare the healing time of lesions in the mucosa of the gastric stoma of children and adolescents using laser therapy versus conventional treatment with protective barrier powder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 10, 2020
CompletedFirst Submitted
Initial submission to the registry
February 26, 2021
CompletedFirst Posted
Study publicly available on registry
April 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2023
CompletedApril 28, 2021
February 1, 2021
1 year
February 26, 2021
April 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Healing time with laser therapy
Healing time in days of treatment since the first session
7 days
Healing time with protective barrier powder
Healing time in days of treatment since the first session
15 days
Study Arms (2)
Laser therapy Treatment Group
EXPERIMENTALTreatment evaluation and follow-up will be done for 15 days. The application of the laser at first will be done three times a week. The application will be by points with continuous or selective technique, which will depend on each patient. The device is a pen type that will be by contact or without contact with the lesion, irradiation and the dose will be according to the calculation for each patient, using power in milliwatt and fluency, where the dose will vary according to area and patient, and may vary from 0.1 to 1J / cm² as calculated. The laser tip will be disinfected before each use with 70% alcohol and later coated with plastic film. Patients, companion and operator will wear specific eye protection glasses and all biosafety rules will be followed during therapy.
Barrier Dust Treatment Group
ACTIVE COMPARATORThe evaluation and follow-up of the treatment will be done for 15 days. The principle application will be made three times a week using the protective barrier powder over the entire affected area, forming a protective barrier when adhering to the skin. For all patients, the injured area will be previously cleaned with 0.9% saline solution.
Interventions
barrier powder in gastric mucosa lesion
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
USaoPauloGH
São Paulo, São Paulo, 05403-000, Brazil
Study Officials
- PRINCIPAL INVESTIGATOR
Juliana Ferreira, PhD
Instituto da Criança HCFMUSP
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2021
First Posted
April 28, 2021
Study Start
August 10, 2020
Primary Completion
August 10, 2021
Study Completion
August 10, 2023
Last Updated
April 28, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share